Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Eric E. Bouhassira, PhD
Researcher Professor, Department of Medicine (Hematology)
Albert Einstein College of Medicine
1300 Morris Park Avenue
Ullmann Building, Room 903A
Bronx, New York, United States
Dr. Eric E. Bouhassira joined the Albert Einstein College of Medicine in 1990. He began studying human embryonic stem cells in 2001. He is Director of the Medical School’s Center for Human Embryonic Stem Cell Research and Professor of Medicine and of Cell Biology. Dr. Bouhassira’s research focuses on developing hematopoietic (blood forming) stem cells that can differentiate into red blood cells, T cells, platelets, and all other cell types that comprise blood. This work could potentially aid patients needing transfusions and also save lives by expanding the immunology diversity of hematopoietic stem cells available for transplant.
Dr. Bouhassira is also interested in epigenetic regulation in the erythoid and hematopoietic lineage with a focus on DNA replication and DNA methylation. Dr. Bouhassira received his BS, MS, and PhD degrees from the Université Pierre et Marie Curie in Paris, France. Dr. Bouhassira also holds the Ingeborg and Ira Rennert Chair in Stem Cell Biology and Regenerative Medicine.
Areas of Research:
Pluripotent stem cells, erythroid differentiation, red blood cells, epigenetics, DNA methylation, DNA replication, bioinformatics, allele-specific expression, gene therapy, hemoglobinopathies
Related Content
-
Webinar Series: Sickle Cell Science: Path to Progress – Serving the Sickle Cell Disease Community Here and Abr...To commemorate Sickle Cell Awareness Mon...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
WHATZ DA COUNTWDC on SCT has dedicated his Organizatio...
-
Sickle Cell Disease Program at Arkansas Children’sArkansas Children's is the only hospital...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
-
Emily Rudd, MSWEmily is a pediatric social worker at Ch...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...